Varian Medical Systems Inc (VAR) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access VAR Annual Income Statement →
From Varian Medical Systems Inc through Jan 03 2020, changes in Jan 01 2021's revenue and cost structure provide insight into profitability trends.
Quarterly Report, GAAP in USD millions
ITEM
(Jan 01 2021)
Q1 2021
(Oct 02 2020) (Jul 03 2020) (Apr 03 2020) (Jan 03 2020)
Revenues
Sales Revenue, Services, Net2.60
Revenue From Contract With Customer Excluding Assessed Tax778.80
Total Revenue778.80
Costs & Expenses
Cost of Goods and Services Sold419.80
Gross Profit359.00
Selling, Administration, Marketing161.90
Depreciation & Amortization0.00
Research and Development Expense72.20
Restructuring, Settlement and Impairment Provisions0.00
Other exp. /-income0.00
Special Items0.00
Total operating costs including COS661.60
Operating income / -loss117.20
Interest Expense1.30
Net Interest Expense / -Income1.30
Investment Income, Interest2.80
Income from affiliates-3.80
Other loss/ -income-8.50
Total costs & expenses654.40
Income & Taxes
Income / -loss before income taxes124.40
Income taxes expenses / -benefit27.60
Income after income taxes96.80
Net income / -loss of other equity0.00
Income / -loss from continuing operations96.80
Non-controlling interests0.00
Other0.30
Net income / -loss96.80
Income / -loss to shareholder96.50
EBIT125.70
EBITD141.70
EBITDA141.70
Earnings Per Share
Basic EPS (excl. extra items)1.06
Basic Net EPS1.06
Basic shares outstanding (Mill. of Units)91.40
Diluted Net EPS1.05
Diluted average shares (Mill. of Units)92.20
4 historic quarters locked

Sign in to unlock the full Varian Medical Systems Inc income statement history.

About VAR Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.